Implications of the serine protease HtrA1 in amyloid precursor protein processing

被引:166
作者
Grau, S
Baldi, A
Bussani, R
Tian, XD
Stefanescu, R
Przybylski, M
Richards, P
Jones, SA
Shridhar, V
Clausen, T
Ehrmann, M [1 ]
机构
[1] Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales
[2] Univ Naples 2, Dept Biochem, Sect Pathol, I-80100 Naples, Italy
[3] Univ Trieste, Dept Pathol, I-34100 Trieste, Italy
[4] Univ Konstanz, Dept Chem & Analyt Chem, D-78457 Constance, Germany
[5] Mayo Clin & Mayo Fdn, Ctr Canc, Dept Expt Pathol, Rochester, MN 55905 USA
[6] Inst Mol Pathol, A-1030 Vienna, Austria
关键词
protein quality control; amyloid beta; C99;
D O I
10.1073/pnas.0501823102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The defining features of the widely conserved HtrA (high temperature requirement) family of serine proteases are the combination of a catalytic protease domain with one or more C-terminal PDZ domains and reversible zymogen activation. Even though HtrAs have previously been implicated in protein quality control and various diseases, including cancer, arthritis, and neuromuscular disorder, the biology of the human family members is not well understood. Our data suggest that HtrA1 is directly involved in the beta-amyloid pathway as it degrades various fragments of amyloid precursor protein while an HtrA1 inhibitor causes accumulation of A beta in astrocyte cell culture supernatants. Furthermore, HtrA1 colocalizes with beta-amyloid deposits in human brain samples. Potential implications in Alzheimer's disease are discussed.
引用
收藏
页码:6021 / 6026
页数:6
相关论文
共 39 条
  • [1] The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells
    Baldi, A
    De Luca, A
    Morini, M
    Battista, T
    Felsani, A
    Baldi, F
    Catricalà, C
    Amantea, A
    Noonan, DM
    Albini, A
    Natali, PG
    Lombardi, D
    Paggi, MG
    [J]. ONCOGENE, 2002, 21 (43) : 6684 - 6688
  • [2] Roles of molecular chaperones in protein misfolding diseases
    Barral, JM
    Broadley, SA
    Schaffar, G
    Hartl, FU
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2004, 15 (01) : 17 - 29
  • [3] CATERSON B, 1983, J BIOL CHEM, V258, P8848
  • [4] Generation of the β-amyloid peptide and the amyloid precursor protein C-terminal fragment γ are potentiated by FE65L1
    Chang, Y
    Tesco, G
    Jeong, WJ
    Lindsley, L
    Eckman, EA
    Eckman, CB
    Tanzi, RE
    Guénette, SY
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (51) : 51100 - 51107
  • [5] A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer
    Chien, J
    Staub, J
    Hu, SI
    Erickson-Johnson, MR
    Couch, FJ
    Smith, DI
    Crowl, RM
    Kaufmann, SH
    Shridhar, V
    [J]. ONCOGENE, 2004, 23 (08) : 1636 - 1644
  • [6] The HtrA family of proteases: Implications for protein composition and cell fate
    Clausen, T
    Southan, C
    Ehrmann, M
    [J]. MOLECULAR CELL, 2002, 10 (03) : 443 - 455
  • [7] Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms
    Czech, C
    Tremp, G
    Pradier, L
    [J]. PROGRESS IN NEUROBIOLOGY, 2000, 60 (04) : 363 - 384
  • [8] High resolution proteome analysis of cryoglobulins using Fourier transform-ion cyclotron resonance mass spectrometry
    Damoc, E
    Youhnovski, N
    Crettaz, D
    Tissot, JD
    Przybylski, M
    [J]. PROTEOMICS, 2003, 3 (08) : 1425 - 1433
  • [9] Pattern of expression of HtrA1 during mouse development
    De Luca, A
    De Falco, M
    De Luca, L
    Penta, R
    Shridhar, V
    Baldi, F
    Campioni, M
    Paggi, MG
    Baldi, A
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 (12) : 1609 - 1617
  • [10] Distribution of the serine protease HtrA1 in normal human tissues
    De Luca, A
    De Falco, M
    Severino, A
    Campioni, M
    Santini, D
    Baldi, F
    Paggi, MG
    Baldi, A
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2003, 51 (10) : 1279 - 1284